For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Search Posts
National Review
How Trump Can Help Reopen America’s Schools
It’s almost the middle of August, and many parents still have little idea if their kids will be able to go to school in a few…
The Wall Street Journal
The White House Prepared for a Pandemic
New York Gov. Andrew Cuomo launched the Democrats’ broadside against the Trump administration’s Covid-19 response. “Our current federal government is dysfunctional and incompetent,” he told…
Letters
CEI Joins Coalition Letter Opposing Most Favored Nation Drug Pricing Proposal
On behalf of the undersigned federal and state-based organizations, we write to express our grave concerns with the “most favored nation” (MFN) executive order to impose foreign…
City Journal
Following The Science — Where?
When doctors meet a patient for a new complaint, we make a list of different possible explanations for the problem—a differential diagnosis—and try to determine…
Inside Sources
Government Contact Tracing Won’t Help Get Americans Back to Work, but Innovation Will
Contact tracing identifies people who have an infectious disease (cases) and people they came in contact with (contacts) who may have become infected.
News Release
Price Controls for Medicines Risk Harming Innovation When Breakthrough Drugs or Vaccines May Mean Life or Death
President Trump is expected to issue an executive order today directing his administration to take a series of actions related to pharmaceuticals and the price…